跳至主要内容
临床试验/NCT04831762
NCT04831762Unknown不适用

MARQUEURS DE DEVELOPPEMENT DE L'ATTENTION EXECUTIVE CHEZ L'ENFANT : POPULATIONS VARIEES

University Hospital, Caen1 个研究点 分布在 1 个国家目标入组 200 人开始时间: 2021年3月1日最近更新:
适应症

试验速览

阶段
不适用
入组人数
200
试验地点
1
主要终点
ANT performance

研究概览

简要总结

Executive attention is essential for emotional and behavioral self-regulation. There is inter-individual variability in the level of efficiency of executive attention from kindergarten entry, and this variability predicts children's academic performance at entry to elementary school and beyond. It is therefore essential to better understand the early stages of executive attention development and self-regulation from an early age in order to develop tools for early detection of executive attention disorders, so that school accommodations can be proposed as early as possible.

In previous work, we have identified early tactile information processing skills that underpin the development of executive attention. We would like to extend this work to a diverse population of preschool children, in order to consider new tools for the early detection of attention disorders. The MEDiATE-PRV project aims to compare the performance obtained in a validated attentional task in preschool children with assessments of tactile information processing, in relation to the psychomotor and executive development of the child. We will include 200 children aged 4 years to 5 years 11 months with different risk factors for ADHD.

研究设计

研究类型
Observational
观察模型
Ecologic Or Community
时间视角
Cross Sectional

入排标准

年龄范围
48 Months 至 71 Months(Child)
性别
All
接受健康志愿者

入选标准

  • Attending preschool
  • Parental informed consent

排除标准

  • 未提供

结局指标

主要结局

ANT performance

时间窗: 48 to 71 months of age

Reaction time in ms to ANT trials with a correct answer

Tactile processing score

时间窗: 48 to 71 months of age

Score to the sensory profile tactile subtest

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验

Markers of Executive Attention Development in... | 临床试验